Quick Detail
Place of Origin
Brand Name
Jinlan
HS-CODE
-
Package & Delivery Lead Time
Package
1g,10g,20g,
Detailed Description
Description
Lenacapavir is a first-in-class, long-acting HIV-1 capsid inhibitor that binds to the viral capsid protein and blocks multiple steps in the HIV lifecycle, including capsid assembly, disassembly, and nuclear entry.
As a long-acting injectable and oral formulation, it provides sustained antiviral activity with a long half-life, enabling less frequent dosing compared to traditional antiretrovirals.
Approved Indications
- Treatment of multi-drug resistant HIV-1 infection in heavily treatment‑experienced adults
- Long‑acting regimen for maintenance therapy in adults with suppressed viral load
Key Features
- First-in-class HIV capsid inhibitor
- Long half-life supports long‑acting administration
- High potency against drug‑resistant HIV strains
- Dual formulations: injectable long‑acting and oral
- High barrier to resistance
Applications
API, intermediates, reference standards for R&D, generic registration and commercial manufacturing.